Physician profile
Aqsa Ullah
NPI 1649710799
$3,052.80
in general payments reported to CMS, 2019-2025
8 companies · $2,816 in 2025
The $2,816 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.51 · 2022: $94.88 · 2024: $114 · 2025: $2,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,151 · Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,150.96 |
| Food and Beverage | $778.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,640.50 | 2025 | |
| Averitas Pharma INC. | $109.65 | 2024-2025 | Qutenza |
| Alnylam Pharmaceuticals INC. | $94.88 | 2022 | |
| Biogen, INC. | $87.72 | 2025 | Spinraza |
| Tanabe Pharma America, INC. | $53.33 | 2020-2025 | Radicava |
| Microtransponder, INC. | $35.91 | 2024 | |
| Abbvie INC. | $17.30 | 2024 | |
| Mdd US Operations, LLC | $13.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aqsa Ullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.